61
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Silica Induces Plasminogen Activator Inhibitor-1 Expression through a MAPKs/AP-1-Dependent Mechanism in Human Lung Epithelial Cells

, , , , , & show all
Pages 561-567 | Received 18 Aug 2007, Accepted 20 Oct 2007, Published online: 20 Oct 2008

REFERENCES

  • Y. Abe, S. Hashimoto, and T. Horie. (1999). Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. Pharmacol. Res. 39:41–47.
  • J.D. Ahn, R. Morishita, Y. Kaneda, K.U. Lee, J.Y. Park, Y.J. Jeon, H.S. Song, and I.K. Lee. (2001). Transcription factor decoy for activator protein-1 (AP-1) inhibits high glucose-and angiotensin II-induced type 1 plasminogen activator inhibitor (PAI-1) gene expression in cultured human vascular smooth muscle cells. Diabetologia 44:713–720.
  • A. Andrew, and A. Barchowsky. (2000). Nickel-induced plasminogen activator inhibitor-1 expression inhibits the fibrinolytic activity of human airway epithelial cells. Toxicol. Appl. Pharmacol. 168:50–57.
  • E.G. Barrett, C. Johnston, G. Oberdörster, and J.N. Finkelstein. (1998). Silica-induced chemokine expression in alveolar type II cells is mediated by TNF-a. Am. J. Physiol. Lung Cell Mol. Physiol. 275:L1110–L1119.
  • P.H. Brown, R. Alani, L.H. Preis, E. Szabo, and M.J. Birrer. (1993). Suppression of oncogene-induced transformation by a deletion mutant of c-jun. Oncogene 8:877–886.
  • P.H. Brown, T.K. Chen, and M.J. Birrer. (1994). Mechanism of action of a dominant-negative mutant of c-Jun. Oncogene 9:791–799.
  • S.H. Cho, C.H. Ryu, and C.K. Oh. (2004). Plasminogen activator inhibitor-1 in the pathogenesis of asthma. Exp. Biol. Med. (Maywood) 229:138–146.
  • L. Chu, T.S. Wang, H.Y. Jiang, Y.B. Hu, and Q.F. Zeng. (2005). In vivo and in vitro silica induces nuclear factor egr-1 activation mediated by ERK 1/2 in RAW 264.7 cell line. Toxicology Mech. Method 15:93–99.
  • T.J. Gross, R.H. Simon, C.J. Kelly, and R.G. Sitrin. (1991). Rat alveolar epithelial cells concomitantly express plasminogen activator inhibitor-1 and urokinase. Am. J. Physiol. 260:L286–L295.
  • B. Guo, K. Inoki, M. Isono, H. Mori, K. Kanasaki, T. Sugimoto, S. Akiba, T. Sato, B. Yang, R. Kikkawa, A. Kashiwagi, M. Haneda, and D. Koya. (2005). MAPK/AP-1-dependent regulation of PAI-1 gene expression by TGF-beta in rat mesangial cells. Kidney int. 68:972–984.
  • E.R. Hahm, G. Cheon, J. Lee, B. Kim, C. Park, and C.H. Yang. (2002). New and known symmetrical curcumin derivatives inhibit the formation of Fos-Jun-DNA complex. Cancer Lett. 184:89–96.
  • M. Hergenhahn, U. Soto, A. Weninger, A. Polack, C.H. Hsu, A.L. Cheng, and F. Rösl. (2002). The chemopreventive compound curcumin is an efficient inhibitor of Epstein-Barr virus BZLF1 transcription in Raji DR-LUC cells. Mol. Carcinog. 33:137–145.
  • X. Hua, Z.A. Miller, G. Wu, Y. Shi, and H.F. Lodish. (1999). Specificity in transforming growth factor beta-induced transcription of the plasminogen activator inhibitor-1 gene: interaction of promoter DNA, transcripition factor muE3, and Smad proteins. Proc. Natl. Acad. Sci. USA. 96:13130–13135.
  • I. Kotani, A. Sato, H. Hayakawa, T. Urano, Y. Takada, and A. Takada. (1995). Increased procoagulant and antifibrinolytic activities in the lungs with idiopathic pulmonary fibrosis. Thromb. Res. 77:493–504.
  • C. Lardot, M. Heusterpreute, P. Mertens, M. Philippe, and D. Lison. (1998). Expression of plasminogen activator inhibitors type-1 and type-2 in the mouse lung after administration of crystalline silica. Eur. Respir. J. 11:912–921.
  • R.K. Maheshwari, A.K. Singh, J. Gaddipati, and R.C. Srimal. (2006). Multiple biological activities of curcumin: a short review. Life Sci. 78:2081–2087.
  • B.C. Marshall, B.R. Brown, M.A. Rothstein, N.V. Rao, J.R. Hoidal, and G.M. Rodgers. (1991). Alveolar epithelial cells express both plasminogen activator and tissue factor. Potential role in repair of lung injury. Chest. 99:25S–27S.
  • J. Øvrevik, M. Låg, P. Schwarze, and M. Refsnes. (2004). p38 and Src-ERK1/2 pathways regulate crystalline silica-induced chemokine release in pulmonary epithelial cells. Toxicol. Sci. 81:480–490.
  • J. Øvrevik, M. Refsnes, E. Namork, R. Becher, D. Sandnes, P.E. Schwarze, and M. Låg. (2006). Mechanisms of silica-induced IL-8 release from A549 cells: initial kinase-activation does not require EGFR activation or particle uptake. Toxicology 227:105–116.
  • C. Park, G.Y. Kim, G.D. Kim, B.T. Choi, Y.M. Park, and Y.H. Choi. (2006). Induction of G2/M arrest and inhibition of cyclooxygenase-2 activity by curcumin in human bladder cancer T24 cells. Oncol. Rep. 15:1225–1231.
  • F. Shen, X. Fan, B. Liu, X. Jia, H. Du, B. You, M. Ye, C. Huang, and X. Shi. (2006). Overexpression of cyclin D1-CDK4 in silica-induced transformed cells is due to activation of ERKs, JNKs/AP-1 pathway. Toxicol. Lett. 160:185–195.
  • A.J. Whitmarsh, and R.J. Davis. (1996). Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J. Mol. Med. 74:589–607.
  • C.H. Woo, J.H. Lim, and J.H. Kim. (2004). Lipopolysaccharide induces matrix metalloproteinase-9 expression via a mitochondrial reactive oxygen species-p38 kinase-activator protein-1 pathway in Raw 264.7 cells. J. Immunol. 173:6973–6980.
  • D.P. Zhang, H. Qiu, Y. Zhuang, and F.Q. Meng. (2007). The effect of curcumin on bleomycin-induced pulmonary fibrosis in rats. Zhonghua Jie He He Hu Xi Za Zhi 30:197–201.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.